Melanotan I is a melanocortin receptor agonist. Argireline is a topical skincare peptide.
They are aimed at different things: Melanotan I at tanning & skin protection; Argireline at anti-wrinkle skincare.
| Comparison | Melanotan I (Afamelanotide) afamelanotide · Scenesse | Argireline (Acetyl Hexapeptide-8) acetyl hexapeptide-8 · acetyl hexapeptide-3 |
|---|---|---|
| How it works | How it works Melanotan I copies alpha-MSH, the hormone that tells skin to make pigment. It is the only compound in this pair that is an approved medicine. | How it works Argireline is marketed as topical Botox. The comparison is directionally right about the target and badly wrong about the magnitude. |
| What it is | The safer, approved tanning peptide for a slow, protective tan. | A topical Botox-like peptide that softens fine lines, needle-free. |
| Status | FDA approvedFDA-approved (Scenesse) | Sold over the counterCosmetic ingredient |
| Typical dose | 0.5–1 mg per day | — |
| How often | Daily then weekly | Daily |
| Dose comes from | Community practice | No established range |
| Cycled? | The approved implant is one every 2 months, about 3 a year FDA drug label | Not cycled Community practice |
| What it does | ||
| Drug class | Melanocortin agonist | Cosmetic peptide (topical) |
| Used for | The safer, approved tanning peptide. It builds a slow, even, protective tan and shifts skin toward real sun defense. It has fewer side effects than its cousin, but is slower and pricier. | A topical Botox-like peptide in many anti-aging serums that relaxes fine expression lines. It is milder and needle-free. |
| Receptors hit | — | — |
| Numbers | ||
| Full dose line | 0.5 up to 1 mg per day (loading phase) | Serum, per product |
| Why that cycle | The approved product is an implant placed every two months, typically three times a year to cover spring and summer. That interval is on the label. The injectable version sold separately is a different product used on a loading-then-maintenance pattern that comes from community practice. | Used daily as part of a routine. The effect depends on continued use and returns to baseline when you stop, so there is nothing to cycle off. |
| Weight / effect | Not measured in a trial | Not measured in a trial |
| Chain length | 13 residues | 6 residues |
| Common vial | 10 mg | — |
| Before you start | ||
| Route | Under the skin (or implant) | On the skin (topical) |
| Do not use if | Pregnancy Approved only for a specific rare light-sensitivity disorder | A known allergy to the ingredient Broken skin |
What separates them
Proof behind the dose. Every dose here comes from community practice. Not one is backed by a published human study, which is worth knowing before you read the numbers as if they were equivalent.
Staying on it. Argireline is taken continuously. Melanotan I is normally run in blocks with breaks, though for this one the block length is convention rather than a tested schedule.
How you take it. Melanotan I is injected. Argireline is taken on the skin, so the milligram numbers are not comparable between them.
What doesn't differ: Neither has a measured effect size from a published trial, so there is no number to rank them on.
What people actually report
Melanotan I (Afamelanotide)
- A cleaner profile than Melanotan II, but you should still watch moles for changes.
- A mole that changes in size, shape, or colour
- Signs of an allergic reaction
Argireline (Acetyl Hexapeptide-8)
- Very safe on the skin; the effect is subtle compared with injectables.
- A rash, swelling, or intense itching where applied
Side effects are what users and trials report most often, not a complete list. Anything sudden, spreading, or breathing-related is an emergency regardless of which compound caused it.
People also compare
This comparison does not cover cost, long-term safety, or how you personally will respond. Effect figures come from separate trials in different populations and are not always directly comparable to each other. Nothing here is medical advice or a recommendation to use any of these. Talk to a clinician about your own situation.